Tuesday, 10 May 2022

Reuters Global Healthcare: WHO chief says China's zero-COVID policy not 'sustainable'

WHO chief says China's zero-COVID policy not 'sustainable'

The head of the World Health Organization said on Tuesday China's zero-tolerance COVID-19 policy is not sustainable given what is now known of the virus, in rare public comments by the U.N. agency on a government's handling of the pandemic.

Pfizer to pay $11.6 bln for Biohaven to tap migraine market

Pfizer Inc said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co , making a big bet on its ability to boost sales of the top-selling pill in a new class of migraine drugs.

Major U.S. retailers limit infant formula purchases on shortage

U.S. retailers including Target Corp , CVS Health Corp and Walgreens Boots Alliance said on Tuesday they have limited purchases of infant formula due to a supply shortage.

At least 3,000 have died in Ukraine for want of disease treatment, WHO says

The World Health Organization's European chief said on Tuesday that at least 3,000 people had died in Ukraine since Russia's invasion in February because they had been unable to access treatments for chronic diseases.

WHO chief says China's zero-COVID policy not 'sustainable'

The head of the World Health Organization said on Tuesday China's zero-tolerance COVID-19 policy is not sustainable given what is known of the disease, in rare public comments by the U.N. agency on a government's handling of the virus.

Test, test, test? Scientists question costly mass COVID checks

Health officials in some countries are questioning the merits of repeated, mass testing when it comes to containing infections, particularly considering the billions it costs.

GE unit boosts medical dye output as China COVID lockdown cuts supplies

General Electric's healthcare unit said on Tuesday it had increased output of dye used for medical scans and tests at its factory in Ireland and shipped products by air to help combat shortages caused by the suspension of its Shanghai factory.

BioNTech completes Phase II trial of COVID-19 vaccine in China

Vaccine developer BioNTech completed a Phase II clinical trial of its COVID-19 vaccine in China in January but has yet to release its results, a registry of such trials showed on Tuesday.

Novavax shares slide 20% on COVID vaccine demand uncertainty

Novavax Inc's shares plunged nearly 20% in premarket trading on Tuesday due to uncertainty over global demand for the company's COVID-19 vaccine following a slow start to deliveries.

World Health Organization members pass resolution against Russia

Members of the World Health Organization's European region passed a resolution on Tuesday that could result in the closure of Russia's regional office and the suspension of meetings in the country in response to its invasion of Ukraine.

Related Videos

Moderna asks FDA to authorize COVID shot for kids

FDA pushes ahead to ban menthol cigarettes

Beijing ups COVID curbs, fears Shanghai-like misery